Filter by

of 1 Next >
Results Found: 1
  • NYU Dataset

    Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia

    Authors
    Robert C. Smith
    Revital Amiaz
    Tian-Mei Si
    Lawrence Maayan
    11 more author(s)...
    Description

    Schizophrenic patients have a high rate of smoking and cognitive deficits which may be related to a decreased number or responsiveness of nicotinic receptors in their brains. Varenicline is a partial nicotinic agonist which is effects as an anti-smoking drug in cigarette smokers, although concerns have been raised about potential psychiatric side-effects. This data is from a double-blind placebo controlled...

    Subject
    Chronic Disease
    Mental Health
    Risk Factors
    Timeframe
    2012
    Access Rights
    Free to All